Whence and wherefore IgE ?
Immunological Reviews · 2024-09 · 326 (1) · 48-65
DOI: 10.1111/imr.13373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 23.07.2024. Verfasst von Rifat S Rahman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Immunoglobulin E. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Despite the near ubiquitous presence of Ig‐based antibodies in vertebrates, IgE is unique to mammals. How and why it emerged remains mysterious. IgE expression is greatly constrained compared to other IgH isotypes. While other IgH isotypes are relatively abundant, soluble IgE has a truncated half‐life, and IgE plasma cells are mostly short‐lived. Despite its rarity, IgE is consequential and can trigger life‐threatening anaphylaxis. IgE production reflects a dynamic steady state with IgG memory B cells feeding short‐lived IgE production. Emerging evidence suggests that IgE may also potentially be produced in longer‐lived plasma cells as well, perhaps as an aberrancy stemming from its evolutionary roots from an antibody isotype that likely functioned more like IgG. As a late derivative of an ancient systemic antibody system, the benefits of IgE in mammals likely stems from the antibody system's adaptive recognition and response capability. However, the tendency for massive, systemic, and long‐lived production, common to IgH isotypes like IgG, were likely not a good fit for IgE. The evolutionary derivation of IgE from an antibody system that for millions of years was good at antigen de‐sensitization to now functioning as a highly specialized antigen‐sensitization function required heavy restrictions on antibody production—insufficiency of which may contribute to allergic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Medicine, Division of Allergy and Clinical Immunology, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Ragon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, USA.
- Broad Institute of MIT and Harvard, Boston, Massachusetts, USA.
ORCID-Profile: Duane R Wesemann
Förderung
- NIAID NIH HHS
Zitieren
APA
Rahman, R. S., & Wesemann, D. R. (2024). Whence and wherefore IgE ?. Immunological Reviews, 326(1), 48-65. https://doi.org/10.1111/imr.13373
Vancouver
Rahman RS, Wesemann DR. Whence and wherefore IgE ?. Immunological Reviews. 2024;326(1):48-65. doi:10.1111/imr.13373
BibTeX
@article{Rahman2024,
author = {Rahman, Rifat S and Wesemann, Duane R},
title = {Whence and wherefore IgE ?},
journal = {Immunological Reviews},
year = {2024},
volume = {326},
number = {1},
pages = {48--65},
doi = {10.1111/imr.13373}
}
EUVIMED